Somatropin - OctoPlus
Alternative Names: OctoDEX-hGHLatest Information Update: 02 Oct 2021
At a glance
- Originator OctoPlus
- Class Growth hormones; Hormonal replacements; Obesity therapies; Recombinant proteins
- Mechanism of Action Human growth hormone replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Growth disorders
Most Recent Events
- 03 Aug 2007 Discontinued - Phase-I for Growth disorders in Netherlands (SC)
- 13 Jul 2005 Phase-I clinical trials in Growth disorders in Netherlands (SC)